Back to Search Start Over

P2.16-03 CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC.

Authors :
Felip, E.
Brahmer, J.
Broderick, S.
Swanson, S.
Awad, M.
Mitsudomi, T.
Girard, N.
Kerr, K.
Spicer, J.
Cai, J.
Yang, R.
Forde, P.
Source :
Journal of Thoracic Oncology; Oct2018 Supplement, Vol. 13, pS831-S832, 2p
Publication Year :
2018

Details

Language :
English
ISSN :
15560864
Volume :
13
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
132777742
Full Text :
https://doi.org/10.1016/j.jtho.2018.08.1478